We also analyzed glioma cell data from the Cancer Cell Line Encyclopedia (CCLE, Methods) to verify if Notch signaling alone was predictive of response to GPX4 inhibitors using in vitro models. The gene discussed is GPX4; the disease is central nervous system cancer.